| Application number | Title of the application | Filing Date | Status |
|---|
| 08/521016 | RECOMBINANT VIRUS IMMUNOTHERAPY | Aug 29, 1995 | Abandoned |
Array
(
[id] => 4257215
[patent_doc_number] => 06204052
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Adenoviral vectors with reduced TNF response and partial E3 region deletion'
[patent_app_type] => 1
[patent_app_number] => 8/515495
[patent_app_country] => US
[patent_app_date] => 1995-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 11283
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204052.pdf
[firstpage_image] =>[orig_patent_app_number] => 515495
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/515495 | Adenoviral vectors with reduced TNF response and partial E3 region deletion | Aug 14, 1995 | Issued |
| 08/698360 | METHOD OF INTRODUCING MODIFICATION INTO A GENE | Aug 14, 1995 | Abandoned |
| 08/515159 | COMPOSITIONS AND METHODS FOR TREATING SPECIFIC GENE EXPRESSION-RELATED DISEASES AND DISORDERS IN HUMANS | Aug 14, 1995 | Abandoned |
| 08/514501 | COMPOSITIONS AND METHODS FOR TREATING GENE EXPRESSION RELATED DISEASES AND DISORDERS IN HUMANS | Aug 10, 1995 | Abandoned |
| 08/510623 | PREVENTION OF BREAST CANCER BY TARGETED DESTRUCTION OF THE MAMMARY EPITHELIUM | Aug 2, 1995 | Abandoned |
Array
(
[id] => 3818694
[patent_doc_number] => 05789653
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Secretory gene trap'
[patent_app_type] => 1
[patent_app_number] => 8/497076
[patent_app_country] => US
[patent_app_date] => 1995-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 7109
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789653.pdf
[firstpage_image] =>[orig_patent_app_number] => 497076
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/497076 | Secretory gene trap | Jun 29, 1995 | Issued |
Array
(
[id] => 3734260
[patent_doc_number] => 05698443
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Tissue specific viral vectors'
[patent_app_type] => 1
[patent_app_number] => 8/495034
[patent_app_country] => US
[patent_app_date] => 1995-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5006
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698443.pdf
[firstpage_image] =>[orig_patent_app_number] => 495034
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/495034 | Tissue specific viral vectors | Jun 26, 1995 | Issued |
Array
(
[id] => 3808980
[patent_doc_number] => 05709844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-20
[patent_title] => 'Transgenic mice expressing HPV early region oncogene develop progressive cervico-vaginal neoplasia'
[patent_app_type] => 1
[patent_app_number] => 8/484997
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12655
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/709/05709844.pdf
[firstpage_image] =>[orig_patent_app_number] => 484997
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484997 | Transgenic mice expressing HPV early region oncogene develop progressive cervico-vaginal neoplasia | Jun 6, 1995 | Issued |
Array
(
[id] => 3726270
[patent_doc_number] => 05702932
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Microinjection methods to transform arthropods with exogenous DNA'
[patent_app_type] => 1
[patent_app_number] => 8/479485
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9233
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702932.pdf
[firstpage_image] =>[orig_patent_app_number] => 479485
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479485 | Microinjection methods to transform arthropods with exogenous DNA | Jun 6, 1995 | Issued |
Array
(
[id] => 4416763
[patent_doc_number] => 06224858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression'
[patent_app_type] => 1
[patent_app_number] => 8/488424
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 39
[patent_no_of_words] => 18561
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/224/06224858.pdf
[firstpage_image] =>[orig_patent_app_number] => 488424
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488424 | Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression | Jun 6, 1995 | Issued |
Array
(
[id] => 3989280
[patent_doc_number] => 05891665
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Untranslated leader sequences from RNA viruses as enhancers of translation'
[patent_app_type] => 1
[patent_app_number] => 8/474010
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 37
[patent_no_of_words] => 7484
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891665.pdf
[firstpage_image] =>[orig_patent_app_number] => 474010
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/474010 | Untranslated leader sequences from RNA viruses as enhancers of translation | Jun 6, 1995 | Issued |
Array
(
[id] => 931173
[patent_doc_number] => 06979677
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-27
[patent_title] => 'Inhibition of vascular smooth muscle cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 08/480038
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4266
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/979/06979677.pdf
[firstpage_image] =>[orig_patent_app_number] => 08480038
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480038 | Inhibition of vascular smooth muscle cell proliferation | Jun 6, 1995 | Issued |
| 08/475992 | ALZHEIMER'S PEPTIDE | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4047053
[patent_doc_number] => 05932241
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Cationic lipid DNA complexes for gene targeting'
[patent_app_type] => 1
[patent_app_number] => 8/480923
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 8568
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932241.pdf
[firstpage_image] =>[orig_patent_app_number] => 480923
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480923 | Cationic lipid DNA complexes for gene targeting | Jun 6, 1995 | Issued |
Array
(
[id] => 4299265
[patent_doc_number] => 06184435
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Transgenic mouse expressing APP770-V717F'
[patent_app_type] => 1
[patent_app_number] => 8/475176
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3366
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184435.pdf
[firstpage_image] =>[orig_patent_app_number] => 475176
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475176 | Transgenic mouse expressing APP770-V717F | Jun 6, 1995 | Issued |
Array
(
[id] => 3659266
[patent_doc_number] => 05667766
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Non-human animal model of a human airway, methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/486920
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4260
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/667/05667766.pdf
[firstpage_image] =>[orig_patent_app_number] => 486920
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486920 | Non-human animal model of a human airway, methods of use | Jun 6, 1995 | Issued |
Array
(
[id] => 1210535
[patent_doc_number] => 06713662
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Production of collagen in the milk of transgenic mammals'
[patent_app_type] => B1
[patent_app_number] => 08/482173
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 11
[patent_no_of_words] => 13287
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713662.pdf
[firstpage_image] =>[orig_patent_app_number] => 08482173
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482173 | Production of collagen in the milk of transgenic mammals | Jun 6, 1995 | Issued |
Array
(
[id] => 1043762
[patent_doc_number] => 06867195
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Lipid-mediated polynucleotide administration to reduce likelihood of subject\'s becoming infected'
[patent_app_type] => utility
[patent_app_number] => 08/486533
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23012
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867195.pdf
[firstpage_image] =>[orig_patent_app_number] => 08486533
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486533 | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected | Jun 6, 1995 | Issued |
| 08/480653 | METHOD FOR IDENTIFYING ALZHEIMER'S DISEASE THERAPEUTICS USING TRANSGENIC ANIMAL MODELS | Jun 6, 1995 | Abandoned |